Persist Ai Raises $4M In Seed Financing, Rapidly Accelerates Drug Formulation

Aug 04, 2023•over 2 years ago

Amount Raised

$4 Million

Round Type

seed

West SacramentoHealth Care

Investors

Pioneer FundY CombinatorFellows FundInnospark Ventures2048 Ventures

Description

Persist AI, the AI-driven pioneer in drug formulation, announced today the close of an oversubscribed $4M financing round following their completion of YCombinator, the prestigious San Francisco based startup accelerator. The funding round was led by 2048 Ventures with the participation of Innospark Ventures, Fellows Fund, YCombinator, Pioneer Fund, and others.

Company Information

Company

Persist AI

Location

890 Embarcadero Dr.

West Sacramento, California, United States

About

Persist AI is revolutionizing pharmaceutical development through AI-driven robotics for formulation development and CMC. By combining predictive AI models with automated robotic systems, Persist AI enables pharmaceutical companies to develop drug formulations in a fraction of the time and cost of traditional approaches. The company works across multiple modalities and formulation types to accelerate bringing novel therapeutics to patients. Persist AI is a Y Combinator-backed company, having graduated from the prestigious startup accelerator in 2023.

Related People

2 contacts

Funding Insights

Based on industry data

VC-backed spending patterns